WARSAW, Ind., March 22, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the introduction of PediFlex™ Advanced, the Company’s next generation elastic nailing platform. The upgrade to the legacy system provides a modified flexible nail implant in multiple diameters and lengths, available in both stainless steel and titanium. The platform includes an innovative new inserter design, allowing for easy assembly and interchangeable collets for multiple nail sizes. Further, PediFlex™ Advanced features enhanced instruments for nail extraction and completes the next step in the evolution of OrthoPediatrics’ intramedullary nailing franchise.
Joe Hauser, OrthoPediatrics’ Vice President of Trauma & Deformity Correction, stated, “We are committed to providing pediatric orthopedic surgeons with the most innovative systems to treat their patients, and flexible nailing is one of the most frequent pediatric implant procedures. The enhancements beyond the first generation PediFlex™ Nail System provide a significant advancement in pediatric fracture care. Additionally, this expansion represents OrthoPediatrics’ commitment to continuous improvement of its products.”
About PediFlex™ Advanced
PediFlex™ Advanced is intended for fixation of diaphyseal fractures of long bones where the medullary canal is narrow or flexibility of the implant is required. This includes upper extremity fractures in all patients and lower extremity fractures in pediatric or small stature patients. In pediatric patients, the flexibility of the nail allows it to be inserted at a point that does not disturb or disrupt the growth plate.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]


DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Apple Restores Telegram to App Store After Content Policy Violation
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 



